Tace With Durvalumab
Tace With Durvalumab entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.
Timeline
Fri, 07 Aug 2026 13:54:51 GMTReviewing the EMERALD-1 Trial of TACE With Durvalumab and Bevacizumab - CancerNetwork
Thu, 30 Jul 2026 07:00:00 GMTESMO GI 2026 Hepatobiliary Cancer Highlights: From TACE Combinations to Precision Cholangiocarcinoma Treatment - Oncodaily
Related explainers
Connected entities
EMERALD2 live mentionsTrial2 live mentionsHepatobiliary Cancer Highlights2 live mentionsFrom TACE Combinations2 live mentionsPrecision Cholangiocarcinoma Treatment2 live mentionsReviewing1 live mentionsBevacizumab1 live mentionsCancerNetwork Reviewing1 live mentionsBevacizumab CancerNetwork CancerNetwork1 live mentionsESMO GI1 live mentions
FAQ
What does this page track?
Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tace With Durvalumab.
Why might this page be noindex?
Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.
Where should readers verify facts?
Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.
Source diversity
2 distinct publisher/source names are currently connected to this entity page.